Compare MRVI & ACDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRVI | ACDC |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2020 | 2021 |
| Metric | MRVI | ACDC |
|---|---|---|
| Price | $7.17 | $4.93 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 4 | 2 |
| Target Price | $4.13 | ★ $5.50 |
| AVG Volume (30 Days) | ★ 3.3M | 1.2M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $185,743,000.00 | ★ $1,941,800,000.00 |
| Revenue This Year | $12.54 | N/A |
| Revenue Next Year | $7.87 | $11.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.55 | $3.08 |
| 52 Week High | $9.42 | $8.22 |
| Indicator | MRVI | ACDC |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 48.73 |
| Support Level | $5.54 | $4.73 |
| Resistance Level | $7.44 | $5.52 |
| Average True Range (ATR) | 0.32 | 0.31 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 64.29 | 30.24 |
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
ProFrac Holding Corp is a technology-focused, vertically integrated energy services company providing hydraulic fracturing, proppant production, completion services, and related products, including distributed power generation, to upstream oil and natural gas companies in the United States. The Company operates through four segments: Stimulation Services, Proppant Production, Manufacturing, and Flotek. The Stimulation Services segment, which generates maximum revenue, provides hydraulic fracturing services using mobile units and auxiliary equipment. The Proppant Production segment supplies proppant, the Manufacturing segment sells engineered products such as pumps, valves, and piping, and Flotek is a chemistry and data technology company serving the E&P industry.